Skip to content

Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden

Effect of Autogenic Relaxation Therapy on Caregivers on Perceived Stress Quality of Life and Caregiver Burden: a Randomized Controlled Study

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06687486
Enrollment
64
Registered
2024-11-13
Start date
2024-11-07
Completion date
2025-02-20
Last updated
2024-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Care Burden, Caregiver, Caregiver Burnout

Brief summary

Caregivers are also faced with multiple stress factors. Autogenic relaxation therapy will help caregivers relax and take time for themselves by getting away from the stressful life they have lived. Although there are various studies on this subject (Chegeni et al. 2018, Seo and Kim 2019, Ramiraz-Garcia et al. 2020, Wang et al. 2021, Bagheri et all 2021, Ozhanlı and Akyuz 2022), there is no study on caregivers as far as we could reach. As a result of this study, nurses will help caregivers, whom they work one-on-one in most areas, to relax, thus helping to increase the quality of patient care in home environments and contributing to the increase in the quality of life of the caregiver. Thus, caregivers will be able to manage care more actively and effectively both at home and in clinics. Based on this purpose, the aim of the study is to reduce the anxiety level of caregivers, increase the quality of life and reduce the burden of care after autogenic relaxation therapy to be applied to caregivers.

Interventions

BEHAVIORALrelaxin

caregivers relaxing and care burden

OTHERkontrol

no intervention

Sponsors

Seda KARAKAYA ERGUN
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Intervention model description

Individuals assigned as intervention and control will complete the research in these groups.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Being over 18 years old * Being able to answer data collection forms * Being able to speak Turkish * Being able to provide continuous or partial care to a patient for at least 3 months * Being able to communicate

Exclusion criteria

* Having epilepsy * Not speaking or understanding Turkish * Having a neurological disability * Having had an acute myocardial infarction * Being diagnosed with schizophrenia and major depression * Being addicted to alcohol or drugs * Having a history of loss of consciousness

Design outcomes

Primary

MeasureTime frameDescription
Principial1 monthA decrease in the perceived stress scale score indicates a decrease in stress, an increase in the quality of life scale score indicates an increase in the quality of life, and a decrease in the care burden scale score indicates a decrease in the care burden. The secondary outcome measure is the decrease in the Perceived Stress Scale score, the increase in the Quality of Life Scale Score, and the decrease in the care burden scale score after autogenic relaxation therapy applied to caregivers.

Secondary

MeasureTime frameDescription
second3 monthThe secondary outcome measure is that caregivers feel better after autogenic relaxation therapy, are able to perform autogenic relaxation therapy on their own, and are least affected by the disadvantages of the care burden.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026